Choice ClinOps serves as the clinical operations command center for small and midsize companies navigating high-risk, high-value oncology, rare disease, and cell and gene therapy programs on a local or global scale.
We act as an extension of the sponsor team, particularly when internal sponsor bandwidth is strained or when specific expertise in clinical operations is lacking. In situations where visibility is diminishing, vendors are misaligned, sites are underperforming, or when significant transitions such as mergers, acquisitions, or changes in CRO/large vendor partnerships create potential disruptions, Choice ClinOps steps in to ensure seamless continuity.
The result is enhanced control, accelerated execution, improved stakeholder alignment, avoidance of excessive spending, and reduced operational risk, all while eliminating the need for the fixed overhead associated with a full-time executive hire. Leila Cupersmith leads this initiative, ensuring that our fractional clinical operations model meets the unique challenges faced by our sponsor clients.
